Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous BG9928 in Acute Decompensated Heart Failure with Renal Insufficiency
2007-007395-42Phase 3Completed
- Sponsor
- Biogen
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in heart failure (HF) and Renal Insufficiency (RI) comparing BG9928 intravenous with Placebo intravenous (2 arms). Primary endpoint: Change in body weight at 24 hours. Started Jun 2008; status: completed.
02
Drugs
tonapofylline
03
Conditions
heart failure (HF)Renal Insufficiency (RI)
Beyond the preview
Go deeper on 2007-007395-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007395-42.